Literature DB >> 864747

R3327 adenocarcinoma of the Copenhagen rat as a model for the study of the immunologic aspects of prostate cancer.

D M Lubaroff, L Canfield, T L Feldbush, W W Bonney.   

Abstract

The Dunning R3327 prostate adenocarcinoma of the Copenhagen rat was developed as a suitable model of human prostate cancer. Inoculation of tumor tissue mince or cells sc in the flanks of recipient rats produced tumors that had the macroscopic and microscopic characteristics of the human disease. The histologic picture of these tumors was that of a well-differentiated adenocarcinoma with the formation of glands and acid secretions within the acini. Tumors were also produced in the dorsolateral lobe of the prostate by the injection of cells. The intraprostate tumor, although initially confined to the injected lobe, grew to involve the surrounding tissues and eventually metastasized to the lymph nodes and lungs. Occasional metastatic lesions were found in other organs also. Acid phosphatase could be domonstrated by histochemical staining of frozen tumor sections, and elevated levels of the enzyme were seen in the sera of rats bearing long-term subcutaneous tumors. During investigation of the tumor, a fast-growing tumor line arose that grew equally as well in females as in males. The histology of this tumor was that of an undifferentiated anaplastic tumor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 864747     DOI: 10.1093/jnci/58.6.1677

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  6 in total

1.  Isolation, in vitro cultivation, and electron microscopy of normal and malignant prostatic epithelial cells from the Copenhagen rat.

Authors:  F A Feuchter; D R Rowley; P M Heidger
Journal:  Urol Res       Date:  1980

2.  Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems.

Authors:  Twan Lammers; Peter Peschke; Rainer Kühnlein; Vladimir Subr; Karel Ulbrich; Peter Huber; Wim Hennink; Gert Storm
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

3.  Immunomodulatory effect of cyclophosphamide on host humoral immunity in Dunning's R-3327 adenocarcinoma of the prostate.

Authors:  R Bhatti; P Ray; N Bell
Journal:  Urol Res       Date:  1991

4.  Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise.

Authors:  Danielle J McCullough; John N Stabley; Dietmar W Siemann; Bradley J Behnke
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

5.  Characterization of a rat model of metastatic prostate cancer bone pain.

Authors:  Paolo Donato De Ciantis; Kiran Yashpal; James Henry; Gurmit Singh
Journal:  J Pain Res       Date:  2010-11-08       Impact factor: 3.133

6.  Development of a locally advanced orthotopic prostate tumor model in rats for assessment of combined modality therapy.

Authors:  Vasu Tumati; Sanjeev Mathur; Kwang Song; Jer-Tsong Hsieh; Dawen Zhao; Masaya Takahashi; Timothy Dobin; Leah Gandee; Timothy D Solberg; Amyn A Habib; Debabrata Saha
Journal:  Int J Oncol       Date:  2013-03-19       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.